AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Treatment of Acne in the Pregnant Patient

Description

The presentation discusses the treatment of acne in pregnant patients, emphasizing its prevalence and the psychological impact it has on women during this period. The speaker highlights various studies, indicating that while some women may experience worsening acne during pregnancy, many feel improved post-delivery. Treatment options are explored, focusing on safe medications and approaches for different trimesters. Benzoyl peroxide, azelaic acid, clindamycin, and topical retinoids like adapalene are among the recommended treatments. The presentation stresses the importance of discussing patient expectations and monitoring acne severity. It also discusses the implications of certain medications during lactation and addresses concerns about dietary supplements, particularly vitamin A, which can be teratogenic in high doses. The speaker encourages a proactive approach to acne management, suggesting systemic medications for severe cases and emphasizing the need for collaboration with ob-gyns. The value of maintaining physical health and the use of myo-inositol, especially for patients with PCOS, is also mentioned as beneficial during pregnancy. Overall, the speaker advocates for effective treatment of acne to alleviate the psychological distress associated with the condition in expecting mothers.

View more

Conclusions

  • Acne is prevalent in pregnancy, with a significant number of women experiencing either worsening or new onset of acne during this time.
  • Most patients with acne during pregnancy report feeling better after delivery, but approximately 60% feel their acne worsens while pregnant.
  • Patients who have irregular menstruation, polycystic ovary syndrome (PCOS), or higher body mass indexes are more likely to experience severe acne in pregnancy.
  • Topical treatments are the first-line approach for managing acne in pregnant patients, with systemic medications considered for more severe cases.
  • Certain topical medications, such as azelaic acid, clindamycin, and erythromycin, are considered safe for use during pregnancy, while others such as tazarotene are contraindicated.
  • Benzoyl peroxide and salicylic acid, though category C, are likely safe for limited use during pregnancy as they have minimal systemic absorption.
  • There is a need for caution regarding dietary supplements containing high doses of vitamin A, as they may pose teratogenic risks to the fetus.
  • The use of myo-inositol during pregnancy is promising and may help reduce the incidence of gestational diabetes and other complications.
  • Collaboration with obstetricians and careful communication of expectations with patients is critical in managing acne during pregnancy and lactation.
  • McMullan P, Yaghi M, Truong TM, Rothe M, Murase J, Grant-Kels JM. Safety of dermatologic medications in pregnancy and lactation: An Update - Part I: Pregnancy. J Am Acad Dermatol. 2024 Jan 25:S0190-9622(24)00109-9.
  • Yaghi M, McMullan P, Truong TM, Rothe M, Murase J, Grant-Kels JM. Safety of dermatologic medications in pregnancy and lactation: An Update - Part II: Lactation. J Am Acad Dermatol. 2024 Jan 25:S0190-9622(24)00109-9.
  • Akash Rau, Jonette Keri, Jenny E Murase Management of Acne in Pregnancy. Am J Clin Dermatol. 2024 Mar 7. doi: 10.1007/s40257-024-00851-6. Online ahead of print.
  • Nussbaum, R. Clin Derm 2006; 24:133-141.
  • Bechstein SK, Ochsendorf F. Acne in pregnancy: Epidemiology, clinical management and patient attitudes. Hautarzt. 2017 Feb;68(2):111-119.
  • Ömer Kutlu, Ayşe Serap Karadağ, et al. Acne in pregnancy: A prospective multicenter, cross-sectional study of 295 patients in Turkey. Int J Dermatol. 2020 Sep;59(9):1098-1105.
  • Ly S, Kamal K, Manjaly P, Barbieri J, Mostaghimi A. Treatment of Acne Vulgaris during Pregnancy and lactation: A Narrative Review, Dermatol Ther 2023 Jan; 13(1):115-130.
  • Murase JE, Heller MM, Butler DC. Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy J Am Acad Dermatol. 2014 Mar;70(3):401.e1-14; quiz 415.
  • Trivedi, N.A ., J. Postgrad Med. 2011:57(2):91-5.
  • Tuffanelli, DL. Ach Dermatol 1982;118(11):876.
  • Kraeling, MK, et al. In vitro percutaneous absorption of the alpha hydroxy acids in human skin J Soc Cosmet Chem 1997; 48:187-97.
  • Munley, SM, et al. Developmental toxicity study of glycolic acid in rats. Drugs Chem Toxicol 1999;22(4):569-82.
  • Selcert, D. Otocerebral anomalies associated with topical tretinoin use. Brain Dev. 2000;22(4):218-20.
  • Autret E. et al. Tazarotene: A systemic review. Lancet 1997;350(9074):339.
  • Weiss J, Mallavalli S, Meckfessel M, Griffin S, Wagner N. Safe Use of Adapalene 0.1 % Gel in a non-Prescription Environment. J Drugs Dermatol. 2021 Dec 1;20(12):1330-1335.
  • Han G, Wu JJ, Del Rosso JQ. Use of Topical Tazarotene for the Treatment of Acne Vulgaris in Pregnancy: A Literature Review. J Clin Aesthet Dermatol. 2020 Sep;13(9).
  • Zamil DH, Burns EK, Perez-Sanchez A, Parke MA, Katta R. Risk of Birth Defects From Vitamin A 'Acne Supplements' Sold Online. Dermatol Pract Concept. 2021 May 20;11(3):e2021075.
  • Dreno, B. Ann Dermatol Venereol. 2008;135(1):27-33.
  • Hale, E.K ., Int J Dermatol 2002; 41:197-203.
  • Zeichner, J. Narrow band UVB therapy for the treatment of acne vulgaris in pregnancy. Arch Derm 2011 147: (5); 537.
  • Zhang M, Goyert G, Lim HW. Folate and phototherapy: What should we inform our patients? J Am Acad Dermatol. 2017 Nov;77(5):958-964.
  • Trivedi MK1,2, Kroumpouzos G3,4, Murase JE1,5 A review of the safety of cosmetic procedures during pregnancy and lactation. Int J Womens Dermatol. 2017 Feb 27;3(1):6-10.
  • Kaplan YC, et al. Pregnancy outcomes following first-trimester exposure to topical retinoids: a systematic review and meta-analysis. Br J Dermatol. 2015 Nov;173(5):1132-41.
  • Baldwin HE. Treating acne during pregnancy and lactation. Cutis. 2015 Jul;96(1):11-2.
  • Zacchè MM1, Caputo L, Filippis S, Zacchè G, Dindelli M, Ferrari A. Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome. Gynecol Endocrinol. 2009 Aug;25(8):508-13.
  • Pezza M, Carlomagno V, Casucci G. Inositol and acne. G Ital Dermatol Venereol. 2015 Dec;150(6):649-53.
  • Soana K Motuhifonua, Luling Lin, Jane Alsweiler, Tineke J Crawford, Caroline A Crowther. Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes. Cochrane Database Syst Rev. 2023 Feb 15;2(2):CD011507.